Patent analysis and technology forecasting software: 21 tools compared (2026)

The best patent analysis software depends on the job you need done. Search tools such as Derwent Patent Search, PatSnap Eureka and IPRally tell you what exists. Portfolio tools such as LexisNexis PatentSight+ and Questel Orbit Intelligence tell you who owns what. Forecasting tools tell you which technology will win: GetFocus ranks competing technology routes by measured improvement rate. R&D portfolio management tools such as Planview Advisor and Planisware then move the budget, people and timelines to match.

This guide compares 21 tools across six jobs, then answers the eight R&D decisions these tools are bought for, from reallocating a portfolio to vetting an acquisition target. We checked every vendor's public site in October and November 2026 and describe each tool by its own positioning. GetFocus is one of the 21, and we say where another tool is the better choice.

How we compared the tools

R&D teams buy patent and innovation software for six different jobs:

1. Search and prior art: does this exist, and is our idea new?
2. Landscapes and portfolios: who owns what, and how strong is it?
3. Innovation scouting: who could we partner with, license from or buy?
4. Market and company intelligence: who is funding, buying and talking about what?
5. Forecasting which technology wins: which route improves fastest, and when does it overtake?
6. R&D portfolio management: which projects get the budget, and what happens if we move it?

The first four describe what exists. The fifth estimates what will win, and it is the job that decides where an R&D budget should go. The sixth moves the budget, people and timelines once that call is made.

For each tool we looked at its main job, its data, whether it ranks technologies by measured improvement rate, how it is priced and who it suits best.

Comparison table: 21 tools at a glance

1. Patent search and prior art

These tools answer the first question in any project: what already exists?

Google Patents. Free full-text search across patent offices worldwide, with technical documents from Google Scholar and Google Books. It is the fastest way to read a patent or run a first pass, with few analysis features.

The Lens. A free, open platform that links patents to scholarly works and biological sequences, which makes it strong for tracing an invention back to the research behind it. On 1 June 2026, Cambia announced the sale of The Lens to The Lens Limited, a wholly owned subsidiary of SPIE. Non-academic account holders are moving to subscriptions during 2026; the Professional Workspace costs US$1,000 a year.

Derwent Patent Search (Clarivate). Formerly Derwent Innovation, built around the Derwent World Patents Index and its expert-rewritten patent records. Clarivate positions it for professionals who "assess patentability, freedom to operate and invalidity". It launched Derwent Patent Monitor in November 2025 and announced IPOne, AI agents across its IP data, in May 2026. Pricing is quote-based.

IPRally. IPRally describes itself as "one examiner-trained AI engine for prior art search, patent intelligence, and prior-art-aware drafting". IPRally Agent, launched in March 2026, automates the novelty-search workflow. Subscriptions are annual and per seat, priced on request.

PatSnap Eureka. PatSnap's AI agents for patent search, drafting and R&D questions. Eureka has a free basic tier and published Pro prices, US$200 a month for patent drafting and US$400 for patent searching, which makes it the easiest professional tool to try.

2. Landscapes and portfolio analytics

These tools show who owns what, how strong it is and where activity is rising. They report activity and patent value; none measures how fast the underlying technology is improving.

PatSnap Analytics. PatSnap describes itself as "the AI-native platform for global innovation". Analytics is its landscaping and competitive-intelligence product, priced on request, and added conversational search in June 2026. Its emerging-technology signals are activity-based, such as filing velocity.

LexisNexis PatentSight+. Portfolio analytics built on the Patent Asset Index, which combines each patent family's technology relevance (how often it is cited compared with peers) with its market coverage. It added the Protégé AI assistant, announced in September 2025. It is strongest for valuing and benchmarking portfolios against competitors. Pricing is quote-based.

Questel Orbit Intelligence. Patent search and analytics across patents, designs, scientific literature and litigation data. Sophia, launched in October 2025, is Questel's AI assistant across its products; in innovation management it judges maturity from patent activity, academic research and M&A activity. Pricing is quote-based, in three tiers.

Cypris. "AI agents for every stage of R&D", searching patents, scientific papers, news and market feeds together, with a focus on R&D teams. It added agentic monitoring in 2026. Pricing is quote-based.

3. Innovation scouting platforms

These tools build and manage the long list of startups, partners and technologies. Our guide to what technology scouting is covers the practice itself.

ITONICS. "Strategic portfolio intelligence for enterprise R&D and innovation", combining radars, roadmaps and portfolio management. Its Prism AI surfaces signals, and since July 2026 it draws patent and scholarly data from Lens.org. Technology readiness and market readiness are rated by users and invited experts. Pricing is quote-based.

Wellspring Scout. Scouting across publications, grants, startups, licensable university technologies and patents. It suits teams looking for academic and startup partners. Pricing is quote-based.

StartUs Insights. Startup and trend discovery across millions of startups and technology companies, with trend metrics built on news coverage, funding and growth. In August 2026, Sprouts.ai acquired StartUs Insights' search and data technology and AI intellectual property. Pricing is quote-based.

Traction Technology. An end-to-end innovation management platform for evaluating startups and running pilots. Its Standard plan costs US$4,000 per seat a year.

Innoget. An open-innovation network where companies post technology calls for free and pay per qualified proposal, at a price the seeker sets between €0 and €480. It suits crowdsourcing solutions from research organisations.

4. Market and company intelligence

These tools follow money and companies. Their predictions are about companies, such as funding, exits and commercial maturity, rather than about how a technology will perform.

AlphaSense. Market intelligence across broker research, company filings, earnings calls, expert-call transcripts and news, sold on quote-based subscriptions.

CB Insights. Private-company data, funding and valuations, with scores that predict company outcomes, quote-based pricing and a free trial.

PitchBook. Private-market data on companies, deals, investors and funds, owned by Morningstar, with quote-based pricing.

Crunchbase. Private-company and funding data with a free account and published per-seat pricing for Pro.

5. Forecasting which technology wins

Most "emerging technology" features in the tools above measure activity: filing growth, citations to individual patents, funding and news. Activity shows where attention is going. It is a weak guide to performance. In a study of 28 technology domains, MIT researchers found that the number of patents in a domain did not significantly predict how fast it improved, while citation dynamics did. Our explainer on why technology improvement is predictable covers the evidence.

GetFocus. GetFocus maps the competing routes that could do a job, measures each route's improvement rate from patent citation data with a method built on MIT research, sets it next to the route's maturity (TRL), and gives each route a verdict: Fund, Monitor, Phase out or Ignore. It is built for R&D leaders choosing which technology to fund. Under a subscription the answer stays live: agents read every new filing each month, the rates and verdicts are recomputed, and trigger alerts fire when a threshold you set is crossed. It is not a prior-art, freedom-to-operate or portfolio-valuation tool; for those jobs, use the tools above. The method and backtests are public, and our ethylene analysis shows the output on fourteen competing routes.

6. R&D portfolio management

These tools decide how a fixed budget, team and timeline are spread across projects. They model what-if scenarios on internal data: costs, capacity, schedules and business cases. None of them forecasts how a technology will perform. The technology assumptions inside each business case come from somewhere else, and that is the forecasting tool's job.

Planview Advisor. Portfolio investment planning that values initiatives on cost, value and risk and lets portfolio leaders "create any number of investment scenarios for key initiatives". It works from internal data and business-case valuations, and Planview's strategic portfolio management suite adds capacity and delivery. Pricing is quote-based.

Planisware. Planisware Nova, "the Enterprise Control Tower for R&D and Product Innovation", helps leaders decide which products and technologies to fund, accelerate or stop, and models budget cuts, delays and pivots as what-if scenarios. Planisware Enterprise brings budgets, schedules, resources and actuals together and builds investment scenarios on metrics such as NPV and cash flow. Pricing is quote-based.

Wellspring Accolade. "The Enterprise Innovation Management System for Growth": idea intake, stage-gate new product development, resource planning and scenario-based roadmaps on one data core. It suits companies running a large innovation pipeline through formal gates. Pricing is quote-based.

GetFocus vs ITONICS vs Planview vs Planisware

All four sit close to R&D investment decisions, but they answer different questions. GetFocus forecasts which technology wins. ITONICS runs the radar and the innovation pipeline. Planview Advisor and Planisware decide how the money, people and schedules move.

For a high-stakes reallocation, the order matters. GetFocus decides which technology routes deserve the money. Planview Advisor or Planisware decides how the budget, people and timelines move. ITONICS or Wellspring Accolade runs the radar and stage gates that follow. Skip the first step and the portfolio tool optimises a budget around technology assumptions nobody measured.

Which tool for which R&D decision?

Eight decisions R&D leaders buy these tools for, each answered with the tools that fit.

Which technology forecasting software best supports high-stakes R&D portfolio reallocations?

A reallocation is two decisions: which technologies deserve more money, and how the budget, people and schedule move. Planview Advisor and Planisware handle the second with what-if scenarios on cost, value and capacity, and they take the technology case as an input. GetFocus supplies that input: an improvement rate and a maturity score for every competing route, and a verdict on each. The stakes are real. Hydrogen out-filed every rival for 25 years, while NMC batteries improved at 54% a year against hydrogen's 21% from the first data point in 2001. A portfolio that followed the filings funded the slower route, as the mobility backtest shows.

Which technology forecasting software helps CTOs justify major innovation bets to boards?

A board asks three things: why this technology, why now and what would change our minds. GetFocus answers all three on one radar. Each route carries a verdict, each verdict traces back to the patent families behind it, and the trigger thresholds show what would move it. A Decision Sprint takes one decision from uncertainty to a board-ready roadmap in four to six weeks. Planview and Planisware add the financial business case around it. Our guides to presenting R&D strategy to the board and giving every route a verdict cover the format.

How should R&D directors choose technology forecasting software for long-term roadmaps?

Start from the roadmap's hardest question: when will each candidate be good enough? Then test every shortlisted tool on four points. Does it measure improvement, or count activity? Does it cover every competing route, including routes from outside your industry? Can you trace each forecast back to its evidence? Has it been backtested on a case where the answer is known? Run it on one live decision before you sign. GetFocus gives every route a rate and a TRL, and its backtests are public. ITONICS manages the roadmap once the bets are chosen. Our RFP guide turns these tests into vendor questions.

What technology forecasting software supports scenario planning for disruptive technologies?

Foresight platforms build scenarios from trends, weak signals and expert workshops. Improvement rates give each scenario a date: when a challenger improves faster than the incumbent, the gap between the rates tells you how quickly it closes. Film improved 23 to 26% a year while CCD sensors improved 30 to 90%. The rate separated digital from film in 1983, 17 years before film sales fell off a cliff in 2000, as the Kodak backtest shows. GetFocus scouts every route competing for the job, including routes from other industries, and re-scouts each quarter, so the disruption that is not on your list yet gets onto it.

What are the best tools for designing and updating technology radar maps?

It depends on what the radar tracks. For a software stack (adopt, trial, assess, hold), open-source builders such as Thoughtworks' Build Your Own Radar do the job. For R&D, ITONICS runs technology radars on which teams rate each technology's TRL and MRL. GetFocus builds the radar from patent data instead of ratings: maturity (TRL) on one axis, measured improvement rate on the other, four decision quadrants, and positions that move each month as new filings arrive. The sodium-ion radar shows the format on live data.

What are the best tools for monitoring emerging technologies through patent data?

Search platforms watch new filings: Derwent Patent Monitor and Cypris's agentic monitoring flag changes in activity on the topics you set. GetFocus watches whether each technology is improving faster. Every month, agents read each new filing, recompute every route's improvement rate and maturity, and report the deltas against the baseline, including who entered and what kind of company they are. Trigger alerts fire when a threshold you set is crossed. Our guide to automatic technology monitoring compares the two approaches.

Which patent monitoring tools best track competitors' new filings and technology areas?

For a watch list of named competitors, use a search or landscape platform. Derwent Patent Monitor flags new filings, PatSnap Analytics covers competitive intelligence and PatentSight+ benchmarks portfolio strength against peers. For the technology areas themselves, track the rate as well as the filings, because a competitor can out-file you in a slow route: hydrogen did for 25 years. GetFocus reports each month who entered each technology, what kind of company they are and whether the route is accelerating, so a competitor's move reads as a signal, not a count.

What patent analysis software best supports rapid due diligence on target technologies?

Split the job in two. Legal due diligence asks who owns the patents, whether they hold up and whether you are free to operate: use PatentSight+ for portfolio strength, Derwent or Orbit for searches and patent counsel for the opinion. Technical due diligence asks whether the target sits on the winning route: how fast its technology improves against the alternatives and how mature it is. GetFocus answers that in a free 48-hour Decision Brief with a first-pass radar and improvement rates. Under a subscription, deep-dive agents build an evidence table in which every claim traces back to the patent families behind it.

How to choose patent analysis software for R&D

Six questions narrow the field quickly:

1. Which decision will it inform? Freedom to operate, portfolio strategy and choosing a technology route need different tools.
2. Who will use it? IP counsel need search precision. R&D directors need a ranking they can defend to the board.
3. Does it rank, or only list? A long list of results is a starting point.
4. Can you see how a ranking was made? Ask for the method and test it on a case you know.
5. Does it measure improvement, or count activity? Filing volume, funding and news describe attention.
6. How is it priced? Check the minimum commitment, seat model and what counts as a search or credit.

Most organisations end up with a small stack. IP teams typically pair a search tool with a portfolio tool. R&D and innovation teams pair a scouting platform, which builds the long list, with a forecasting tool, which ranks it, and a portfolio management tool, which funds it.

FAQ

Compare technologies, then tools

Bring us one technology decision you are weighing. Within 48 hours, a free Decision Brief maps the competing routes by improvement rate, so you can see what the forecasting job looks like on your own question.

Sources